SECOND MALIGNANCIES IN 559 PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB FRONTLINE: DATA FROM THE GIMEMA CML WORKING PARTY

被引：0

作者：

Gugliotta, G. ^{[1
]}

Castagnetti, F. ^{[1
]}

Palandri, F. ^{[1
]}

Breccia, M. ^{[2
]}

Radaelli, F. ^{[3
]}

Capucci, A. ^{[4
]}

Cavazzini, F. ^{[5
]}

Ferrero, D. ^{[6
]}

Stagno, F. ^{[7
]}

Gherlinzoni, F. ^{[4
]}

Di Lorenzo, R. ^{[4
]}

Leoni, P. ^{[8
]}

Cambrin, G. Rege ^{[6
]}

Ferrara, F. ^{[4
]}

Alimena, G. ^{[2
]}

Martinelli, G. ^{[1
]}

Pane, F. ^{[9
]}

Saglio, G. ^{[6
]}

Baccarani, M. ^{[1
]}

Rosti, G. ^{[1
]}

机构：

[1] Univ Bologna, S Orsola M Malpighi Hosp, Inst L & Seragnoli, Bologna, Italy

[2] Univ Roma La Sapienza, Dept Haematol, Rome, Italy

[3] Univ Milan, Dept Haematol, Milan, Italy

[4] Haematol Unit, Brescia, Italy

[5] Univ Ferrara, Dept Haematol, I-44100 Ferrara, Italy

[6] Univ Turin, Dept Haematol, Turin, Italy

[7] Univ Catania, Dept Haematol, Catania, Italy

[8] Univ Ancona, Dept Haematol, Ancona, Italy

[9] Univ Naples Federico II, Dept Haematol, Naples, Italy

来源：

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0805

引用

页码：337 / 337

页数：1

共 50 条

[41] Alternating Nilotinib 400 mg twice daily and Imatinib 400 mg once daily as Frontline Treatment of Ph plus Chronic Myeloid Leukemia. A Phase 2 Multicentric Study of the GIMEMA CML Working Party
Castag-Netti, Fausto
Rosti, Gianantonio
Breccia, Massimo
Gozzini, Antonella
Stagno, Fabio
Cambrin, Giovanna Rege
Pierri, Ivana
Luciano, Luigia
Specchia, Giorgina
Abruzzese, Elisabetta
Martino, Bruno
Capucci, Adele
Bocchia, Monica
Cavazzini, Francesco
Tiribelli, Mario
Gugliotta, Gabriele
Palandri, Francesca
Durante, Sandra
Soverini, Simona
Testoni, Nicoletta
Pane, Fabrizio
Saglio, Giuseppe
Alimena, Giuliana
Martinelli, Giovanni
Baccarani, Michele
BLOOD, 2011, 118 (21) : 209 - 210
[42] Monitoring response and treatment outcome in patients with chronic phase chronic myeloid leukemia (CML) treated with imatinib
Teitelbaum, A.
Spencer, D.
Bollu, V. K.
Chastek, B.
Coombs, J.
Kulakodlu, M.
Morlock, R.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[43] GENERIC IMATINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN CHRONIC PHASE: UPDATED DATA FROM A TURKISH CML COHORT
Eskazan, A. E.
Ayer, M.
Kantarcioglu, B.
Demirel, N.
Aydin, D.
Aydinli, F.
Yokus, O.
Sadri, S.
Erdogan, I.
Berk, S.
Yalniz, F. F.
Elverdi, T.
Salihoglu, A.
Ar, M. C.
Aydin, S. Ongoren
Baslar, Z.
Aydin, Y.
Tuzuner, N.
Ozbek, U.
Soysal, T.
HAEMATOLOGICA, 2015, 100 : 447 - 448
[44] Outcomes in Patients with Chronic Myeloid Leukemia (CML) Who Are Treated with Imatinib As Front Line Therapy
Sweet, Kendra L.
Al Ali, Najla H.
Lancet, Jeffrey E.
Creelan, Ben
Tinsley, Sara
Shah, Bijal D.
Zhang, Ling
Komrokji, Rami S.
Pinilla-Ibarz, Javier
BLOOD, 2012, 120 (21)
[45] Imatinib in the treatment of CML patients ≥ 65 years old in late chronic phase:: Results of a phase II study of the GIMEMA CML working party.
Bassi, S
Castagnetti, F
Amabile, M
Giannini, B
Cilloni, D
Izzo, B
De Vivo, A
Luatti, S
Testoni, N
Rege-Cambrin, G
Iacobucci, I
Gottardi, E
Pane, F
Salvatore, F
Dorigo, A
Saglio, G
Martinelli, G
Rosti, G
Baccarani, M
BLOOD, 2004, 104 (11) : 802A - 802A
[46] The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis
Castagnetti, Fausto
Gugliotta, Gabriele
Breccia, Massimo
Specchia, Giorgina
Abruzzese, Elisabetta
Levato, Luciano
Cavazzini, Francesco
Iurlo, Alessandra
Stagno, Fabio
Ferrero, Dario
Porretto, Ferdinando
Martino, Bruno
Rupoli, Serena
Intermesoli, Tamara
Fava, Carmen
Palandri, Francesca
Venturi, Claudia
Soverini, Simona
Testoni, Nicoletta
Alimena, Giuliana
Pane, Fabrizio
Saglio, Giuseppe
Martinelli, Giovanni
Baccarani, Michele
Rosti, Gianantonio
BLOOD, 2012, 120 (21)
[47] Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: By the GIMEMA working party on chronic myeloid leukemia
Soverini, Simona
Colarossi, Sabrina
Gnani, Alessandra
Rosti, Gianantonio
Castagnetti, Fausto
Poerio, Angela
Iacobucci, Ilaria
Amabile, Marilina
Abruzzese, Elisabetta
Orlandi, Ester
Radaelli, Franca
Ciccone, Fabrizio
Tiribelli, Mario
di Lorenzo, Roberto
Caracciolo, Clementina
Izzo, Barbara
Pane, Fabrizio
Saglio, Giuseppe
Baccarani, Michele
Martinelli, Giovanni
CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7374 - 7379
[48] Impact of age in the outcome of patients with chronic myeloid leukemia in late chronic phase: Clinical and molecular results of a phase II study of the GIMEMA CML working party.
Martinelli, Giovanni
Palandri, Francesca
Iacobucci, Ilaria
Bassi, Simona
Castagnetti, Fausto
Amabile, Marilina
Cilloni, Daniela
Poerio, Angela
Soverini, Simona
Rege-Cambrin, Giovanna
Iuliano, Franco
Alimena, Giuliana
Latagliata, Roberto
Testoni, Nicoletta
Pane, Fabrizio
Saglio, Giuseppe
Rosti, Gianantonio
Baccarani, Michele
BLOOD, 2006, 108 (11) : 286B - 286B
[49] Long-term outcome of complete cytogenetic responders after imatinib 400 mg in late chronic phase, Philadelphia-positive chronic myeloid leukemia: The GIMEMA working party on CML
Palandri, Francesca
Iacobucci, Ilaria
Martinelli, Giovanni
Amabile, Marilina
Poerio, Angela
Testoni, Nicoletta
Soverini, Simona
Castagnetti, Fausto
De Vivo, Antonio
Breccia, Massimo
Specchia, Giorgina
Abruzzese, Elisabetta
Martino, Bruno
Cilloni, Daniela
Saglio, Giuseppe
Pane, Fabrizio
Liberati, Anna Marina
Rosti, Gianantonio
Baccarani, Michele
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (01) : 106 - 111
[50] Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis
Marzocchi, Giulia
Castagnetti, Fausto
Luatti, Simona
Baldazzi, Carmen
Stacchini, Monica
Gugliotta, Gabriele
Amabile, Marilina
Specchia, Giorgina
Sessarego, Mario
Giussani, Ursula
Valori, Laura
Discepoli, Giancarlo
Montaldi, Anna
Santoro, Alessandra
Bonaldi, Laura
Giudici, Giovanni
Cianciulli, Anna Maria
Giacobbi, Francesca
Palandri, Francesca
Pane, Fabrizio
Saglio, Giuseppe
Martinelli, Giovanni
Baccarani, Michele
Rosti, Gianantonio
Testoni, Nicoletta
BLOOD, 2011, 117 (25) : 6793 - 6800

← 1 2 3 4 5 →